VRTX
NASD Vertex Pharmaceuticals Incorporated$499.74 ↑ +0.00 (+0.00%) Trading Up from the previous close of $499.74, $12.47 below the day’s high of $512.21
- YTD change
- +10.23%
- vs 20-day SMA
- -2.13%
- vs 200-day SMA
- +5.06%
Price ranges
Price & Performance
+58.54 (+13.27%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 10.8% away from all-time highs of $560.25
- VRTX is up 10% since the beginning of the year
- VRTX is up 22% over the past 12 months
- VRTX is down 3% over the past 1 month
- 2% of all VRTX investors are betting against VRTX
VRTX reads neutral: price sits above one of the two key moving averages, the 12-month move is +19.9%.
- Previous minute
- +$0.00
- Last hour
- -$3.13
- Last 5 days
- -0.70%
- vs 8-day SMA
- -0.57%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
